Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-11

Clinical Trial Update: Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of obeticholic acid for primary biliary cholangitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Obeticholic acid (obeticholic acid)

Snippet

Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical | Conditions: Primary Biliary Cholangitis | Phase 3 | Status: COMPLETED